Article
Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia.
JCI insight - 22 May 2024
Giménez Yari, Palacios Manuel, Sánchez-Domínguez Rebeca, Zorbas Christiane, Peral Jorge, Puzik Alexander, Ugalde Laura, Alberquilla Omaira, Villanueva Mariela, Río Paula, Gálvez Eva, Da Costa Lydie, Strullu Marion, Catala Albert, Ruiz-Llobet Anna, Segovia Jose Carlos, Sevilla Julián, Strahm Brigitte, Niemeyer Charlotte M, Beléndez Cristina, Leblanc Thierry, Lafontaine Denis Lj, Bueren Juan, Navarro Susana
Abstract excerpt
This study lays the groundwork for future lentivirus-mediated gene therapy in patients with Diamond Blackfan anemia (DBA) caused by mutations in ribosomal protein S19 (RPS19), showing evidence of a new safe and effective therapy. The data show that, unlike patients with Fanconi anemia (FA), the hematopoietic stem cell (HSC) reservoir of patients with DBA was not significantly reduced, suggesting that collection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
